来自POMC腹神经元的乳头类阿片类药物会激活糖的胃口
Marielle Minère1,2, Hannah Wilhelms1, Bojana Kuzmanovic3
1Research Group Synaptic Transmission in Energy Homeostasis, Max Planck Institute for Metabolism Research, Cologne, Germany.
概括
科学家们发现, 促进腹感的神经元 (POMC) 也会激活糖的胃口. 这一发现揭示了为什么我们渴望糖果,
科学领域:
- 神经生物学
- 调节食欲
- 代谢神经科学
背景情况:
- 高糖摄入是常见的,即使是饭后,表明复杂的食欲调节.
- 在腹时选择性食用糖的神经生物学基础尚不清楚.
- 下丘脑中的亲黑皮质神经元 (POMC) 是满足感的关键调节者,减少食物摄入量.
研究的目的:
- 研究在腹状态下对糖的选择性胃口背后的神经生物学机制.
- 确定下丘脑POMC神经元在饮食后对糖的渴望中的作用.
主要方法:
- 使用小鼠模型研究神经元活动和信号通路.
- 研究POMC神经元投射到副腹腔体.
- 在糖消耗和腹感的背景下检查了片受体信号.
主要成果:
- 发现POMC神经元在促进腹的同时也激活了糖的胃口.
- 确定了一种特定的阿片类循环,涉及到POMC神经元投射到副腹腔丘脑.
- 这种循环在糖消费期间表现出强烈的活化,特别是在和状态下.
- 抑制这种循环减少了足小鼠的高糖饮食摄入量.
结论:
- 下垂体POMC神经元有两种作用:促进和启动糖食欲.
- 一个POMC神经元驱动的mu-opioid通道在副腹腔体中介于腹时的糖渴望.
- 针对这一新发现的循环可能提供管理过度消费糖的策略.
更多相关视频
07:29Real-time Analysis of Gut-brain Neural Communication: Cortex wide Calcium Dynamics in Response to Intestinal Glucose Stimulation
Published on: December 29, 2023
581
07:24Combining Quantitative Food-intake Assays and Forcibly Activating Neurons to Study Appetite in Drosophila
Published on: April 24, 2018
8.2K
相关概念视频
Regulation of Food Intake
179
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
179
Gustation
47.6K
Gustation is a chemical sense that, along with olfaction (smell), contributes to our perception of taste. It starts with the activation of receptors by chemical compounds (tastants) dissolved in the saliva. The saliva and filiform papillae on the tongue distribute the tastants and increase their exposure to the taste receptors.
47.6K
Glucagon-like Receptor Agonists
291
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
291
Opioid Receptors: Overview
439
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
439
Analgesia and Pain Management
429
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
429
Feedback Loops
55.6K
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
55.6K
